{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidhmzpoa33ck5oqdxmpnk4cswywtmpnay4gmudpeabda5jom3mtiq",
    "uri": "at://did:plc:nzm6xlhdk3myu4xft63gxqp4/app.bsky.feed.post/3mkz4mnd3svh2"
  },
  "path": "/markets/dr-lal-pathlabs-q4-results-review-icici-securities-cuts-target-price-despite-revenue-growth-check-potential-upside-11445143",
  "publishedAt": "2026-05-04T05:58:49.000Z",
  "site": "https://www.ndtvprofit.com",
  "tags": [
    "Markets"
  ],
  "textContent": "The brokerage highlighted that network expansion, entry into high-end radiology and geographic diversification remain key growth drivers for Dr. Lal, though near-term risks include rising competition,...",
  "title": "Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results - Here's Why"
}